PlainPharmaWatch

CMS Open Payments · Program Year 2024

Anika Therapeutics, Inc.

Anika Therapeutics, Inc. reported $1,210,418.58 in payments to 1,041 physicians and teaching hospitals across 1,058 transactions.

See the rankings → How this is sourced
$1.2M
Total payments
1,058
Transactions
1,041
Recipients
−$471.6K
General Payments vs PY2023

Anika Therapeutics, Inc. reported $1,210,418.58 in payments to 1,041 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #578 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $1.2K per recipient across 4 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Anika Therapeutics, Inc. pairs above-median payment volume with a broadly spread payment pattern across many recipients.

#578
of 1,925 companies
0.0%
of all US industry payments
0.3%
paid to its single top recipient
4
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Anika Therapeutics, Inc.'s CMS-reported General Payments decreased by $471.6K (−29.3%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: ANIKA THERAPEUTICS, INC.PY2023: ANIKA THERAPEUTICS, INC.PY2024: Anika Therapeutics, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$1.6MPY2024$1.1M
PY2023
$1,608,875.81
PY2024
$1,137,255.40

How Anika Therapeutics, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Anika Therapeutics, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$1,210,419 Top 30% higher than 70% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). This entry sits in this band. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Anika Therapeutics, Inc.

Rank #578 of 1,925 companies in CMS Open Payments for 2024 belongs to Anika Therapeutics, Inc., which reported $1,210,418.58 across 1,058 transactions to 1,041 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $1.1K per transaction and $1.2K per recipient.

"Royalty or License" leads the 4-category general-payment breakdown below at $752.2K (62.1% of the company's reported total, 126 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

Anika Therapeutics, Inc. made 4 types of general payments. "Royalty or License" is the largest category at $752.2K, 62.1% of the company's reported total.

How Anika Therapeutics, Inc. divides its payments

General-payment categories, ordered by reported total

1. Royalty or License$752.2K2. Consulting Fee$300.4K3. Food and Beverage$57.7K4. Travel and Lodging$26.9K
Payment Type Amount Transactions
Royalty or License $752.2K 126
Consulting Fee $300.4K 110
Food and Beverage $57.7K 730
Travel and Lodging $26.9K 75

Recipient Concentration in General Payments

The five largest recipient relationships account for $681,142.82 (59.9%) of $1,137,255.40 in this company's General Payments records across 555 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Anika Therapeutics, Inc.

The five named recipients with the highest reported General Payments from this company

Anthony Miniaci$326.0KArnold-Peter C Weiss$118.7KChristopher E Baker$89.3KBruce R Werber$74.5KTimothy P Codd$72.7K
  1. 1

    Anthony Miniaci

    $325,991.36 across 40 reported transactions

  2. 2

    Arnold-Peter C Weiss

    $118,715.65 across 16 reported transactions

  3. 3

    Christopher E Baker

    $89,272.49 across 31 reported transactions

  4. 4

    Bruce R Werber

    $74,509.40 across 4 reported transactions

  5. 5

    Timothy P Codd

    $72,653.92 across 18 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $1.1K. Average per recipient: $1.2K.

Total Amount

$1,210,418.58

Avg per Transaction

$1.1K

Avg per Recipient

$1.2K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Anika Therapeutics, Inc. Share

0.0%

#578 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Anika Therapeutics, Inc.

Agilent Technologies, Inc.

$1.2M 61 recipients

Pulmonx Corporation

$1.2M 4,502 recipients

FX Shoulder Solutions, Inc

$1.2M 657 recipients

Perspectum Diagnostics Ltd

$1.2M 148 recipients

Spinal Surgical Strategies, Inc.

$1.2M 2 recipients

Braeburn Inc.

$1.2M 12,568 recipients

Frequently Asked Questions

How much did Anika Therapeutics, Inc. pay to physicians and hospitals in 2024? ▾
Anika Therapeutics, Inc. made $1,210,418.58 in payments to physicians and hospitals in Program Year 2024, across 1,058 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Anika Therapeutics, Inc.? ▾
Averaging $1.2K per recipient, Anika Therapeutics, Inc.'s 2024 payments reached 1,041 physicians and teaching hospitals.
What types of payments did Anika Therapeutics, Inc. make? ▾
Anika Therapeutics, Inc. made 4 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Royalty or License" at $752.2K, representing 62.1% of the company's reported total.
How does Anika Therapeutics, Inc. rank among pharmaceutical companies? ▾
Out of 1,925 companies in the CMS Open Payments database for 2024, Anika Therapeutics, Inc. ranks #578 by total payment amount.
What is the average payment size from Anika Therapeutics, Inc.? ▾
The average transaction from Anika Therapeutics, Inc. was $1.1K in 2024. The company made 1,058 total transactions to 1,041 recipients.
Where does the payment data for Anika Therapeutics, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Anika Therapeutics, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.